| کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن | 
|---|---|---|---|---|
| 10750569 | 1050302 | 2015 | 7 صفحه PDF | دانلود رایگان | 
عنوان انگلیسی مقاله ISI
												MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3
												
											دانلود مقاله + سفارش ترجمه
													دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
																																												کلمات کلیدی
												
											موضوعات مرتبط
												
													علوم زیستی و بیوفناوری
													بیوشیمی، ژنتیک و زیست شناسی مولکولی
													 زیست شیمی
												
											پیش نمایش صفحه اول مقاله
												 
												چکیده انگلیسی
												Although miR-564 was reported to be dysregulated in human malignancy, the function and mechanism of miR-564 in tumorigenesis remains unknown. In the present study, we found that miR-564 frequently downregulated in lung cancer cells and significantly inhibited cell proliferation, cell cycle progression, motility, and the tumorigenicity of lung cancer cells. Moreover, we identified zic family member 3 (ZIC3) as a direct target of miR-564. ZIC3 overexpression impaired the suppressive effects of miR-564 on the capacity of lung cancer cells for proliferation and motility. Finally, we detected the expression level of miR-564 and ZIC3 protein in tissue specimens, and found a significant negative correlation between them. Patients with low levels of miR-564 showed a poorer overall survival. Taken together, our present study revealed the tumor suppressor role of miR-564, indicating restoration of miR-564 as a potential therapeutic strategy for the treatment of lung cancer.
											ناشر
												Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical and Biophysical Research Communications - Volume 467, Issue 4, 27 November 2015, Pages 690-696
											Journal: Biochemical and Biophysical Research Communications - Volume 467, Issue 4, 27 November 2015, Pages 690-696
نویسندگان
												Bin Yang, Lin Jia, Qiaojuan Guo, Hui Ren, Desheng Hu, Xiaoyi Zhou, Qingrong Ren, Yanping Hu, Tao Xie,